GreenGro Technologies Develops Sterile Hemp, Cannabis Strains
Genobreeding, a wholly-owned seed genetics subsidiary of GreenGro Technologies, is using triploid methodology to develop the company’s own proprietary hemp and cannabis strains.
The threat of cross-pollination poses one of the most severe risks to a successful farming season. Having a crop pollinated is a severe hit for biomass farmers and catastrophic for anyone in the trimmed flower business. Farmers will never have to worry about pollination again with the advent of triploid hemp and cannabis strains.
Introducing triploid genetics to hemp and cannabis is an important step forward in modernizing the cannabis crop. To maximize yield, cannabidiol (CBD) hemp and marijuana producers prefer female plants, and this is accomplished by using expensive feminized seed, vegetatively propagated female clones, or by removing male plants from dioecious seed lots. This whole process is labor intensive and costly. Triploid (sterile) hemp/marijuana strains will eliminate these hurdles and risk of cross pollination.
“Our Genobreeding seed genetics division continues to introduce new and innovative technologies and breeding methodologies such as the use of triploid technology in breeding hemp and cannabis, a significant step forward in modernizing both crops,” said James Haas, chairman and COO of GreenGro Technologies, Inc. “Our triploid technology should enable our customers across the industry to grow some of the highest quality and disease resistant hemp and cannabis strains available.”
